#USA #Aflac Incorporated #Columbus #dividend increase #Q3 2026

Aflac Incorporated's Financial Overview for Q3 2026

Aflac Incorporated, a premier provider of supplemental health insurance, disclosed its financial performance for the third quarter of 2026 on November 4, revealing noteworthy trends as the company prepares for its future. Notably, Aflac's net earnings for this quarter amounted to $303 million, which translates to $0.61 per diluted share. This marks a steep decline compared to last year's earnings of $1.6 billion or $3.08 per diluted share.

Adjusted Earnings Insights

The adjusted earnings for the third quarter totaled $1.2 billion, a decrease of 8.5% from last year’s figures. The adjusted earnings per diluted share saw a modest decline of 2.4%, noted at $2.43. A significant portion of adjusted earnings benefitted from reserve remeasurement gains amounting to $453 million. Overall, the company's annualized return on average shareholders' equity was recorded at 4.1%. Excluding the impact of foreign currency fluctuations, the annualized adjusted return on equity positioned at 23.7%.

Aflac highlighted its commitment to shareholders by returning approximately $1.1 billion through share repurchase and dividends, demonstrating a solid strategy focused on delivering shareholder value. The board declared a fourth quarter dividend of $0.61 per share, marking an impressive 44 consecutive years of dividend increases.

Performance in Japan and the U.S.

Focusing on Aflac's operations in Japan, the company ceded around ¥500 billion in reserves related to cancer insurance policies to its subsidiary, Aflac Re Bermuda, a strategic move reflective of its overall business adjustments. Aflac Japan reported total adjusted revenues in yen that were slightly down at ¥343.2 billion, while total net earned premiums dropped 2.0% year-over-year.

In the U.S. market, net earned premiums saw a 3.3% increase to $1.5 billion, attributed to improved sales of supplemental health products. With total adjusted revenues reaching $1.8 billion, the segment posted a considerable jump in pretax adjusted earnings, rising by 31.5% compared to the previous year.

Investment Strategy and Future Focus

Aflac continues to emphasize a balanced approach in deploying capital toward growth initiatives while enhancing long-term value for all stakeholders involved. According to Daniel P. Amos, Chairman and CEO of Aflac, the company remains committed to addressing the evolving needs of their customer base, especially in Japan, where they offer innovative products designed to meet various life stages of policyholders.

In summary, although Aflac Incorporated's quarterly results demonstrate a decline in net earnings compared to the previous year, the strategic maneuvers and continued focus on shareholder returns and customer needs signify a promising outlook for the upcoming quarters. The sustained commitment to dividend increases and substantial returns to shareholders reflect Aflac's long-standing reputation as a reliable partner in supplemental health insurance.